Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q4 Loss of $0.33
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $228.65 --0%
Financial Fact:
Research and development: 83.17M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 83.17M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) reported Q4 EPS of ($0.33), $0.01 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $20.5 million versus the consensus estimate of $20.9 million.
For earnings history and earnings-related data on Alnylam Pharmaceuticals, Inc. (ALNY) click here.
For earnings history and earnings-related data on Alnylam Pharmaceuticals, Inc. (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- STAAR Surgical (STAA) PT Lowered to $28 at Stifel After Net-Positive Earnings Call
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
